
Micah Paul Young
Examiner (ID: 7687, Phone: (571)272-0608 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1615, 1618 |
| Total Applications | 1410 |
| Issued Applications | 631 |
| Pending Applications | 181 |
| Abandoned Applications | 616 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18946995
[patent_doc_number] => 11890267
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Benzonatate modified release solid tablets and capsules
[patent_app_type] => utility
[patent_app_number] => 17/573333
[patent_app_country] => US
[patent_app_date] => 2022-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 20501
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573333 | Benzonatate modified release solid tablets and capsules | Jan 10, 2022 | Issued |
Array
(
[id] => 17561682
[patent_doc_number] => 20220125831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => REGENERATIVE CO2 TREATMENT SYSTEM AND METHOD
[patent_app_type] => utility
[patent_app_number] => 17/572025
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572025
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572025 | REGENERATIVE CO2 TREATMENT SYSTEM AND METHOD | Jan 9, 2022 | Pending |
Array
(
[id] => 18953781
[patent_doc_number] => 20240042108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => Orthopedic Internal Fixation Implanted Medical Device
[patent_app_type] => utility
[patent_app_number] => 18/267708
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267708
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/267708 | Orthopedic Internal Fixation Implanted Medical Device | Dec 27, 2021 | Pending |
Array
(
[id] => 18434446
[patent_doc_number] => 20230181740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => VISCOSIFIED FLUIDS FOR MEDICAMENT DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/551289
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551289
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/551289 | VISCOSIFIED FLUIDS FOR MEDICAMENT DELIVERY | Dec 14, 2021 | Pending |
Array
(
[id] => 18921254
[patent_doc_number] => 20240024258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => TREATMENT REGIMEN FOR ONCHYOMYCOSIS USING ALLYLAMINE ANTIFUNGAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/256446
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256446
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/256446 | TREATMENT REGIMEN FOR ONCHYOMYCOSIS USING ALLYLAMINE ANTIFUNGAL COMPOSITIONS | Dec 6, 2021 | Pending |
Array
(
[id] => 18953563
[patent_doc_number] => 20240041890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => ANTI-HAIR-LOSS COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/255027
[patent_app_country] => US
[patent_app_date] => 2021-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255027
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/255027 | ANTI-HAIR-LOSS COMPOSITION | Nov 24, 2021 | Pending |
Array
(
[id] => 19674573
[patent_doc_number] => 12186411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Labeled probe and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/521974
[patent_app_country] => US
[patent_app_date] => 2021-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 11590
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17521974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/521974 | Labeled probe and methods of use | Nov 8, 2021 | Issued |
Array
(
[id] => 19049148
[patent_doc_number] => 20240091117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => SKIN-CLEANSING PRODUCT AND METHOD FOR OBTAINING SAID PRODUCT
[patent_app_type] => utility
[patent_app_number] => 18/254904
[patent_app_country] => US
[patent_app_date] => 2021-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254904
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/254904 | SKIN-CLEANSING PRODUCT AND METHOD FOR OBTAINING SAID PRODUCT | Nov 4, 2021 | Pending |
Array
(
[id] => 18893632
[patent_doc_number] => 20240009117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => ENHANCED UPTAKE TRANSMUCOSAL DRUG DELIVERY COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/252012
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252012
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/252012 | ENHANCED UPTAKE TRANSMUCOSAL DRUG DELIVERY COMPOSITIONS AND METHODS OF USE | Nov 1, 2021 | Pending |
Array
(
[id] => 17503264
[patent_doc_number] => 20220096366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => PROGRAMMABLE PHARMACEUTICAL COMPOSITIONS FOR CHRONO DRUG RELEASE
[patent_app_type] => utility
[patent_app_number] => 17/496234
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17496234
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/496234 | Programmable pharmaceutical compositions for chrono drug release | Oct 6, 2021 | Issued |
Array
(
[id] => 17921521
[patent_doc_number] => 11464742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Extended release compositions comprising trihexyphenidyl
[patent_app_type] => utility
[patent_app_number] => 17/482672
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 25982
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482672
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482672 | Extended release compositions comprising trihexyphenidyl | Sep 22, 2021 | Issued |
Array
(
[id] => 17569838
[patent_doc_number] => 11318090
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-05-03
[patent_title] => In situ gelling composition as a pH-selective and mucoadhesive sustained release drug delivery system
[patent_app_type] => utility
[patent_app_number] => 17/464745
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 9158
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17464745
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/464745 | In situ gelling composition as a pH-selective and mucoadhesive sustained release drug delivery system | Sep 1, 2021 | Issued |
Array
(
[id] => 18656267
[patent_doc_number] => 20230302161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => MRI CONTRAST MEDIUM INCLUDING CARBON-13-CONTAINING GRAPHENE QUANTUM DOT AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 18/042806
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042806
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042806 | MRI CONTRAST MEDIUM INCLUDING CARBON-13-CONTAINING GRAPHENE QUANTUM DOT AND PREPARATION METHOD THEREFOR | Aug 24, 2021 | Pending |
Array
(
[id] => 19059029
[patent_doc_number] => 11938224
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-03-26
[patent_title] => Benzonatate modified release solid tablets and capsules
[patent_app_type] => utility
[patent_app_number] => 17/406137
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15641
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17406137
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/406137 | Benzonatate modified release solid tablets and capsules | Aug 18, 2021 | Issued |
Array
(
[id] => 18626213
[patent_doc_number] => 20230284994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => PET-CT IMAGING METHODS, CONTRAST AGENTS AND PHARMACEUTICAL COMPOSITIONS FOR USE IN SAID IMAGING METHODS
[patent_app_type] => utility
[patent_app_number] => 18/019752
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019752
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/019752 | PET-CT IMAGING METHODS, CONTRAST AGENTS AND PHARMACEUTICAL COMPOSITIONS FOR USE IN SAID IMAGING METHODS | Aug 5, 2021 | Pending |
Array
(
[id] => 19423712
[patent_doc_number] => 12083103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Tacrolimus for improved treatment of transplant patients
[patent_app_type] => utility
[patent_app_number] => 17/444402
[patent_app_country] => US
[patent_app_date] => 2021-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 34972
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17444402
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/444402 | Tacrolimus for improved treatment of transplant patients | Aug 3, 2021 | Issued |
Array
(
[id] => 17625669
[patent_doc_number] => 20220160684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => Extended Release Methazolamide Formulation
[patent_app_type] => utility
[patent_app_number] => 17/394059
[patent_app_country] => US
[patent_app_date] => 2021-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17394059
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/394059 | Extended release methazolamide formulation | Aug 3, 2021 | Issued |
Array
(
[id] => 18596102
[patent_doc_number] => 20230270893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => GALLIUM-LABELED GASTRIN ANALOGUE AND USE IN A METHOD OF IMAGING CCKB-RECEPTOR-POSITIVE TUMORS OR CANCERS
[patent_app_type] => utility
[patent_app_number] => 18/040024
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040024
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040024 | GALLIUM-LABELED GASTRIN ANALOGUE AND USE IN A METHOD OF IMAGING CCKB-RECEPTOR-POSITIVE TUMORS OR CANCERS | Jul 29, 2021 | Pending |
Array
(
[id] => 18595877
[patent_doc_number] => 20230270666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => NOVEL GASTRORETENTIVE EXTENDED RELEASE DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 18/007247
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007247
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007247 | NOVEL GASTRORETENTIVE EXTENDED RELEASE DOSAGE FORM | Jul 27, 2021 | Abandoned |
Array
(
[id] => 19777245
[patent_doc_number] => 12226265
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Method for manufacturing marker with aerated hydrogel
[patent_app_type] => utility
[patent_app_number] => 17/373906
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 9659
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17373906
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/373906 | Method for manufacturing marker with aerated hydrogel | Jul 12, 2021 | Issued |